您的位置: 首页 > 农业专利 > 详情页

Compositions and methods for treating cancer with anti-CD33 immunotherapy
专利权人:
Lentigen Technology, Inc.;The United States of America, as represented by the Secretary, Department of Health and Human Services
发明人:
Rimas Orentas,Dina Schneider,Boro Dropulic,Dimiter S. Dimitrov,Zhongyu Zhu
申请号:
US15934770
公开号:
US10426797B2
申请日:
2018.03.23
申请国别(地区):
US
年份:
2019
代理人:
摘要:
Chimeric antigen receptors containing CD33 antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical compositions, relating to the chimeric antigen receptors are also disclosed. Methods of treating or preventing cancer in a subject, and methods of making chimeric antigen receptor T cells are also disclosed.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充